A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2015 by OncoGenex Technologies
Information provided by (Responsible Party):
OncoGenex Technologies
ClinicalTrials.gov Identifier:
First received: June 26, 2012
Last updated: September 1, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2017
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)